Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001641172-25-002493
Filing Date
2025-04-02
Accepted
2025-04-02 21:55:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 16889
2 ex99-1.htm EX-99.1 14760
  Complete submission text file 0001641172-25-002493.txt   33226
Mailing Address 2601 INSLAND PLACE TOWER 510 KINGS RD N POINT HONG KONG K3 999999999
Business Address
Chan Heng Fai Ambrose (Filed by) CIK: 0001261725 (see all company filings)

Type: SCHEDULE 13D

Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Subject) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94944 | Film No.: 25807281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)